Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Experian 'top pick', says JPMorgan

(Sharecast News) - JPMorgan Cazenove said on Monday that Experian was its top pick in the European business services sector, along with Bureau Veritas, both of which it rates at 'overweight'. "Experian remains our most-preferred long-term pick in European business services, and a top pick for the rest of 2024," it said.

"We have confidence the company will grow at least high single digit percentage organically in the medium term supported by its high-quality portfolio of new products at different stages of development.

"For FY Mar-25, we forecast 8%. Experian has a strong balance sheet and opportunities for value-add acquisitions, on top of continued organic investments."

In the same research note - in which it reinstated coverage of Experian, Bunzl, Bureau Veritas, Intertek and SGS - JPM also said it was positive on the testing, inspection and certification (TIC) space, given the supportive volume outlook for 2024.

The bank said its preferred name at this stage is Bureau Veritas, where it see better-for-longer growth in 2024/25E supported by the secular drivers of TIC but also the company's unique Marine & Offshore asset.

While it is 'neutral' on Intertek, JPM said it was placing the company on 'positive catalyst watch' into Q1 reporting, as it sees positive revenue trends from all three and for Intertek specifically it expects a circa 2% support from two more working days in January to April.

Bunzl and SGS were reinstated at 'neutral'.

Share this article

Related Sharecast Articles

Goldman Sachs downgrades SSP to 'sell', prefers WH Smith
(Sharecast News) - Goldman Sachs downgraded SSP on Monday to 'sell' from 'neutral' "on a relative basis" as it took a look at European travel concessions.
UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.